A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 Diabetes
Public ClinicalTrials.gov record NCT02119819. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Comparison of the Oxyntomodulin Analog, LY2944876, to Once-Weekly Exenatide and to Placebo in Patients With Type 2 Diabetes
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The main purpose of this study is to compare the safety and effectiveness of the study drug known as LY2944876 to exenatide extended-release and placebo in participants with type 2 diabetes mellitus. All drugs will be given by an injection under the skin. Participants remain on stable doses of metformin, as prescribed by their personal investigator if they were on metformin at study entry. Participants' involvement in the study is expected to last about 30 weeks.
Study identification
- NCT ID
- NCT02119819
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 420 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 31, 2014
- Primary completion
- Jul 31, 2015
- Completion
- Sep 30, 2015
- Last update posted
- May 26, 2021
2014 – 2015
United States locations
- U.S. sites
- 31
- U.S. states
- 14
- U.S. cities
- 30
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| John Muir Physician Network Clinical Research Center | Concord | California | 94520 | — |
| Valley Endocrine, Fresno | Fresno | California | 93720 | — |
| National Research Institute | Los Angeles | California | 90057 | — |
| Desert Medical Group Inc | Palm Springs | California | 92262 | — |
| Artemis Institute for Clinical Research | San Diego | California | 92103 | — |
| Encompass Clinical Research | Spring Valley | California | 91978 | — |
| Meridien Research | Bradenton | Florida | 34208 | — |
| M & O Clinical Research, LLC | Fort Lauderdale | Florida | 33316 | — |
| Suncoast Research Group, LLC | Miami | Florida | 33135 | — |
| Suncoast Clinical Research | New Port Richey | Florida | 34652 | — |
| Compass Research | Oviedo | Florida | 32765 | — |
| Clinical Research of Central Florida | Winter Haven | Florida | 33880 | — |
| University of Hawaii | Honolulu | Hawaii | 96813 | — |
| East West Medical Institute | Honolulu | Hawaii | 96814 | — |
| Rocky Mountain Diabetes and Osteoporosis Center | Idaho Falls | Idaho | 83404 | — |
| Iderc, P.L.C. | Des Moines | Iowa | 50314 | — |
| Cotton O'Neil Diabetes and Endocrinology Center | Topeka | Kansas | 66606 | — |
| Mercy Medical Research Institute | Springfield | Missouri | 65807 | — |
| St John's Mercy Medical Center | St Louis | Missouri | 63141 | — |
| Mercy Health Research | Washington | Missouri | 63090 | — |
| Southern New Hampshire Diabetes and Endocrinology | Nashua | New Hampshire | 03063 | — |
| High Point Clinical Trials Center | High Point | North Carolina | 27265 | — |
| Lillestol Research LLC | Fargo | North Dakota | 58103 | — |
| The Corvallis Clinic P.C. | Corvallis | Oregon | 97330 | — |
| Blair Medical Associates, Inc. | Altoona | Pennsylvania | 16602 | — |
| Texas Diabetes and Endocrinology | Austin | Texas | 78731 | — |
| Dallas Diabetes Endocrine Center | Dallas | Texas | 75230 | — |
| San Gabriel Clinical Research | Georgetown | Texas | 78626 | — |
| Oakwell Clinical Research | San Antonio | Texas | 78218 | — |
| Southwest Health Associates, P.A. | Sugar Land | Texas | 77478 | — |
| Wade Family Medicine | Bountiful | Utah | 84010 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 20 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02119819, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 26, 2021 · Synced Sep 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02119819 live on ClinicalTrials.gov.